BI
FLNA

BVF Inc’s Filana Therapeutics FLNA Stock Holding History

BVF Inc’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-325,509
Closed -$1.3M – 46
2017
Q4 		$1.3M Buy
325,509
+1
+0% +$4 0.16% 41
2017
Q3 		$1.32M Hold
325,508
– – 0.17% 37
2017
Q2 		$1.34M Buy
325,508
+1
+0% +$5 0.21% 33
2017
Q1 		$2.04M Hold
325,507
– – 0.35% 29
2016
Q4 		$1.3M Hold
325,507
– – 0.26% 26
2016
Q3 		$2.28M Buy
325,507
+18,377
+6% +$304K 0.43% 26
2016
Q2 		$4.71M Hold
307,130
– – 1% 25
2016
Q1 		$4.79M Buy
307,130
+42,508
+16% +$550K 1.19% 22
2015
Q4 		$3.24M Buy
264,622
+131,942
+99% +$1.75M 0.55% 23
2015
Q3 		$1.7M Buy
+132,680
New +$1.67M 0.34% 25
2013
Q4 		– Sell
-336,761
Closed -$6.41M – 28
2013
Q3 		$6.41M Hold
336,761
– – 1.1% 18
2013
Q2 		$5.21M Buy
+336,761
New +$7.12M 1.01% 16

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BVF Inc's FLNA Position: Q1 2018 in Review

BVF Inc sold out of Filana Therapeutics (FLNA) in Q1 2018, closing a stake of 325,509 shares — an estimated $1.3M sold.

BVF Inc first reported a position in FLNA in Q2 2013 and held it in 12 quarters. The position peaked at $6.41M in Q3 2013. 26 funds tracked by Wall St. Rank hold FLNA as of Q1 2018.

  • BVF Inc reported no remaining Filana Therapeutics position as of Q1 2018 after selling out during the quarter.
  • BVF Inc sold 325,509 Filana Therapeutics shares in Q1 2018, an estimated $1.3M.
  • BVF Inc first reported a position in Filana Therapeutics in Q2 2013 and held it in 12 quarters.
  • BVF Inc's Filana Therapeutics position peaked at $6.41M in Q3 2013.
  • 26 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2018.

Based on BVF Inc's 13F filing for Q1 2018, filed 7 May 2018.